Workflow
CEL-SCI (CVM)
icon
Search documents
CEL-SCI (CVM) - 2019 Q2 - Quarterly Report
2019-05-14 20:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to ______________. Commission File Number 001-11889 CEL-SCI CORPORATION Colorado 84-0916344 State or other jurisdiction incorporation (IRS) ...
CEL-SCI (CVM) - 2019 Q1 - Quarterly Report
2019-02-14 21:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to ______________. Commission File Number 001-11889 CEL-SCI CORPORATION Colorado 84-0916344 State or other jurisdiction incorporation (IR ...
CEL-SCI (CVM) Presents At BIO CEO & Investor Conference - Slideshow
2019-02-12 20:37
| --- | --- | --- | --- | |---------------------|---------------------------------------|--------------------------------------------------------------------------------|---------------------| | | | | | | | | | | | | | | | | | | | | | | | | | | February 2019 | | | | | CEL-SCI Corporation | Geert Kersten Chief Executive Officer | 8229 Boone Boulevard, Suite 802 Vienna, VA 22182, USA - Phone: (703) 506-9460 | NYSE American: CVM | Forward Looking Statements This presentations contains "forward-looking statemen ...